Description
Tavin Tablets: A Comprehensive Overview
Tavin Tablets contain Tenofovir Disoproxil Fumarate (TDF) 1$300\text{ mg}$, an antiretroviral medicine classified as a nucleotide reverse transcriptase inhibitor (NtRTI).2 Doctors use this potent antiviral drug for the treatment of:
-
HIV-1 infection in adults and adolescents, always in combination with other antiretroviral agents.3
-
Chronic Hepatitis B virus (HBV) infection.
TDF works by interfering with the viral replication process.4 It is a prodrug that is converted intracellularly to its active form, tenofovir diphosphate.5 This active metabolite then competes with the natural substrate deoxyadenosine triphosphate and incorporates into the viral DNA chain, causing chain termination. This action effectively blocks the replication of the HIV Reverse Transcriptase and the HBV DNA Polymerase enzymes, thereby reducing the viral load, improving immune function, and delaying the progression of HIV-related illness.6
Usage, Administration, and Therapeutic Protocols
This medication is typically taken orally once daily, with or without food (though administration with food may improve bioavailability and patient tolerability).7 Tavin is used as a foundational component (backbone) of combination antiretroviral therapy (cART) for HIV or as a standalone agent for chronic HBV monoinfection.8
Strict adherence to the prescribed once-daily therapy is critical, as missing doses significantly increases the risk of the virus developing resistance to the drug.
-
HIV/HBV Co-infection: In patients co-infected with HIV and HBV, TDF is a preferred choice as it treats both viruses simultaneously.9 Discontinuation of TDF in these patients requires close clinical and laboratory follow-up for several months due to the risk of severe acute exacerbation (flare-up) of Hepatitis B.10
-
Renal Impairment: TDF is primarily excreted by the kidneys. Dosage adjustments (prolonged dosing intervals) are often required in adults with impaired kidney function (creatinine clearance $< 50\text{ mL/min}$).
Manufacturing, Safety, and Monitoring
Emcure Pharmaceuticals, a well-established name in the HIV treatment landscape, manufactures Tavin Tablets.
| Common Side Effects | Important Safety and Monitoring | Clinical Relevance |
| Nausea, vomiting, diarrhea, flatulence, headache, fatigue, abdominal pain, rash. | Kidney Function Changes: TDF is associated with a risk of renal impairment, including proximal renal tubulopathy and, in rare cases, acute renal failure. | Regular monitoring of serum creatinine, estimated creatinine clearance, and urine protein/glucose is essential (e.g., at baseline, and then every 3-6 months). Dose adjustment or alternative therapy may be necessary if kidney function declines. |
| Bone Loss: Long-term TDF use can be associated with decreased Bone Mineral Density (BMD) and increased risk of fractures/osteomalacia due to its effect on the kidney tubules (hypophosphatemia). | Bone Health: Patients should be advised on regular exercise and calcium/Vitamin D supplementation. Monitoring of serum phosphorus and BMD may be needed. | |
| Severe Acute Exacerbation of HBV: Flare-ups can occur if the medication is stopped, which can lead to hepatic decompensation. | HBV/HIV Status: All patients should be tested for both HIV and HBV before starting therapy. HBV-infected patients who stop Tavin must be monitored closely for liver function. | |
| Lactic Acidosis/Severe Hepatomegaly: Rare but serious. | Monitor for symptoms like unusual muscle pain, shortness of breath, and severe abdominal pain. |
Availability & Purchase Information
Genetec Lifesciences makes Tavin Tenofovir Tablets available. All medicines are sourced directly from Emcure or authorized vendors.
Disclaimer
This site provides product information for informative purposes only. The product image belongs to its respective company. Genetec Lifesciences acts as a wholesaler and distributor, not a manufacturer. We source our medicines directly from the company or its authorized vendors.